Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol, Version 6, 08 Jul 2020, MHRA
Table of Contents
Page Number(s):
D. Arrangements for notification
E. Identifying serious breaches
G. Organisation Responsibilities
Appendix I - Expectations for Specific Serious Breach Topics
Appendix II Examples of Serious Breaches Notified to MHRA (this is not an exhaustive list)
Source: Medicines & Healthcare products Regulatory Agency, the UK.
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demandACROSS Global Training AcademyOnline
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Próximos ensayos clínicos
-
National Institute of Medical Sciences and Nutrition...Aún no reclutandoRhA - Artritis Reumatoide
-
Institute of Liver and Biliary Sciences, IndiaAún no reclutandoInsuficiencia hepática aguda sobre crónicaIndia
-
Centre Leon BerardAún no reclutandoCáncer gástrico | Cáncer de la unión esogástricaFrancia
-
TC Erciyes UniversityReclutamientoEfecto de diferentes soluciones de irrigación sobre el dolor posoperatorio y la curación de lesionesEnfermedad endodónticaPavo
-
Casa di Cura Privata 'Malzoni - Villa dei Platani...ReclutamientoCirugía | Endometriosis profundaItalia
-
Assembly BiosciencesAún no reclutandoHerpes simple genital recurrente tipo 2Nueva Zelanda
-
Cerenovus, Part of DePuy Synthes Products, Inc.Aún no reclutandoAccidente cerebrovascular isquémico agudoEstados Unidos
-
Pamukkale UniversityAún no reclutandoVejiga Urinaria HiperactivaPavo
-
China-Japan Friendship HospitalAún no reclutandoObesidad | Diabetes | Cálculos biliares | Estasis biliar
-
AstraZenecaDaiichi SankyoAún no reclutandoCáncer de mama metastásico | Cáncer de mama HER2 positivo | Cáncer de mama irresecable | Cáncer de mama con baja expresión de HER2Canadá
-
Chinese University of Hong KongReclutamiento
-
Central Hospital, Nancy, FranceAún no reclutando